search
Back to results

Study the Effect of Blood Transfusion on Oxidant-antioxidant Status in Term and Near-term Neonates

Primary Purpose

Blood Transfusion Complication, Oxidative Stress

Status
Completed
Phase
Early Phase 1
Locations
Egypt
Study Type
Interventional
Intervention
packed red blood cells transfusion
Sponsored by
Rania Ali El-Farrash
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Blood Transfusion Complication

Eligibility Criteria

35 Weeks - 37 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Premature neonates ≤36 weeks in need for blood transfusion.

Exclusion Criteria:

  • Critically ill neonates.(perinatal asphaxia,on high setting mechanical ventilation,different types of shock eg ;septic shock and major congenital anomalies)
  • Extremely low birth weight neonates(<1000gm birth weight )
  • Recipient of blood transfusion before enrollment in the study.
  • Neonates planned for exchange transfusion .

Sites / Locations

  • Rania Farrash

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Fresh PRBCs

Old PRBCs

Arm Description

Neonates will receive fresh packed red blood cells transfusion within 7 days of donation

Neonates will receive fresh packed red blood cells transfusion older than 7 days yet within the standard range accepted universally will be transfused to this group.

Outcomes

Primary Outcome Measures

malondialdehyde
MDA
total antioxidant capacity
TAC
serum Copper
s.Cu
serum Zinc
s.Zn
serum magnesium
s.Mg
serum iron
s.Fe
serum Calcium
s.Ca

Secondary Outcome Measures

Full Information

First Posted
August 7, 2017
Last Updated
August 31, 2020
Sponsor
Rania Ali El-Farrash
search

1. Study Identification

Unique Protocol Identification Number
NCT03767361
Brief Title
Study the Effect of Blood Transfusion on Oxidant-antioxidant Status in Term and Near-term Neonates
Official Title
Study the Effect of Blood Transfusion on Oxidant-antioxidant Status in Term and Near-term Neonates
Study Type
Interventional

2. Study Status

Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
June 13, 2018 (Actual)
Primary Completion Date
November 1, 2019 (Actual)
Study Completion Date
February 26, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Rania Ali El-Farrash

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Primary aim is to evaluate the effect of blood transfusion on oxidant-antioxidant status in premature neonates. Secondary aim is to assess the effect of the age of transfused red blood cells on the biological markers of oxidative stress.
Detailed Description
Oxidant-antioxidant status will be assessed by measuring total antioxidant capacity (TAC) and malondialdehyde (MDA), as well as antioxidant minerals, in 65 term and near-term neonates.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Blood Transfusion Complication, Oxidative Stress

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
65 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Fresh PRBCs
Arm Type
Active Comparator
Arm Description
Neonates will receive fresh packed red blood cells transfusion within 7 days of donation
Arm Title
Old PRBCs
Arm Type
Active Comparator
Arm Description
Neonates will receive fresh packed red blood cells transfusion older than 7 days yet within the standard range accepted universally will be transfused to this group.
Intervention Type
Biological
Intervention Name(s)
packed red blood cells transfusion
Intervention Description
packed red blood cells transfusion
Primary Outcome Measure Information:
Title
malondialdehyde
Description
MDA
Time Frame
2-3 hours posttransfusion
Title
total antioxidant capacity
Description
TAC
Time Frame
2-3 hours posttransfusion
Title
serum Copper
Description
s.Cu
Time Frame
2-3 hours posttransfusion
Title
serum Zinc
Description
s.Zn
Time Frame
2-3 hours posttransfusion
Title
serum magnesium
Description
s.Mg
Time Frame
2-3 hours posttransfusion
Title
serum iron
Description
s.Fe
Time Frame
2-3 hours posttransfusion
Title
serum Calcium
Description
s.Ca
Time Frame
2-3 hours posttransfusion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Weeks
Maximum Age & Unit of Time
37 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Premature neonates ≤36 weeks in need for blood transfusion. Exclusion Criteria: Critically ill neonates.(perinatal asphaxia,on high setting mechanical ventilation,different types of shock eg ;septic shock and major congenital anomalies) Extremely low birth weight neonates(<1000gm birth weight ) Recipient of blood transfusion before enrollment in the study. Neonates planned for exchange transfusion .
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rania A. El-Farrash, M.D
Organizational Affiliation
Ain Shams University
Official's Role
Study Director
Facility Information:
Facility Name
Rania Farrash
City
Cairo
ZIP/Postal Code
11381
Country
Egypt

12. IPD Sharing Statement

Learn more about this trial

Study the Effect of Blood Transfusion on Oxidant-antioxidant Status in Term and Near-term Neonates

We'll reach out to this number within 24 hrs